Sequential use of Ad26-based vaccine regimens in NHP to induce immunity against different disease targets

The adenovirus (Ad)26 serotype–based vector vaccine Ad26.COV2.S has been used in millions of subjects for the prevention of COVID-19, but potentially elicits persistent anti-vector immunity. We investigated if vaccine-elicited immunity to Ad26 vector–based vaccines significantly influences antigen-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Selina, Salisch, Nadine C., Gil, Ana Izquierdo, Boedhoe, Satish, Boer, Karin Feddes-de, Serroyen, Jan, Schuitemaker, Hanneke, Zahn, Roland C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664441/
https://www.ncbi.nlm.nih.gov/pubmed/36379957
http://dx.doi.org/10.1038/s41541-022-00567-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664441/
https://www.ncbi.nlm.nih.gov/pubmed/36379957
http://dx.doi.org/10.1038/s41541-022-00567-w

Ejemplares similares